205 related articles for article (PubMed ID: 14706334)
1. p21Waf1/Cip1 as a therapeutic target in breast and other cancers.
Weiss RH
Cancer Cell; 2003 Dec; 4(6):425-9. PubMed ID: 14706334
[TBL] [Abstract][Full Text] [Related]
2. F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation.
Malashicheva AB; Kislyakova TV; Aksenov ND; Osipov KA; Pospelov VA
Oncogene; 2000 Aug; 19(34):3858-65. PubMed ID: 10951579
[TBL] [Abstract][Full Text] [Related]
3. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
4. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.
Weiss RH; Randour CJ
Cell Signal; 2000 Jun; 12(6):413-8. PubMed ID: 10889470
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
6. p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine.
Alpan RS; Pardee AB
Cell Growth Differ; 1996 Jul; 7(7):893-901. PubMed ID: 8809407
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate.
Gorospe M; Shack S; Guyton KZ; Samid D; Holbrook NJ
Cell Growth Differ; 1996 Dec; 7(12):1609-15. PubMed ID: 8959328
[TBL] [Abstract][Full Text] [Related]
8. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
9. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
Lee AW; Nambirajan S; Moffat JG
Oncogene; 1999 Dec; 18(52):7477-94. PubMed ID: 10602507
[TBL] [Abstract][Full Text] [Related]
10. Role of p21WAF1 in the cellular response to UV.
Fotedar R; Bendjennat M; Fotedar A
Cell Cycle; 2004 Feb; 3(2):134-7. PubMed ID: 14712074
[TBL] [Abstract][Full Text] [Related]
11. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
Boulaire J; Fotedar A; Fotedar R
Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
[TBL] [Abstract][Full Text] [Related]
12. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53.
Fang L; Igarashi M; Leung J; Sugrue MM; Lee SW; Aaronson SA
Oncogene; 1999 May; 18(18):2789-97. PubMed ID: 10362249
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.
Cariou S; Donovan JC; Flanagan WM; Milic A; Bhattacharya N; Slingerland JM
Proc Natl Acad Sci U S A; 2000 Aug; 97(16):9042-6. PubMed ID: 10908655
[TBL] [Abstract][Full Text] [Related]
14. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
15. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
16. DNA damage uncouples the mitogenic response to IGF-I in MCF-7 malignant breast cancer cells by switching the roles of PI3 kinase and p21WAF1/Cip1.
Clark MA; Perks CM; Winters ZE; Holly JM
Int J Cancer; 2005 Sep; 116(4):506-13. PubMed ID: 15818613
[TBL] [Abstract][Full Text] [Related]
17. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of MCF-7 breast cancer cell proliferation by 5alpha-dihydrotestosterone; a role for p21(Cip1/Waf1).
Greeve MA; Allan RK; Harvey JM; Bentel JM
J Mol Endocrinol; 2004 Jun; 32(3):793-810. PubMed ID: 15171713
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
Liu W; Zhang R
Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
[TBL] [Abstract][Full Text] [Related]
20. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
